Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James J. Barry Insider Profile
4 Followers
James J. Barry, President & CEO, Director at InspireMD, holds 71.25K shares in BioSig Technologies (Ticker: BSGM), holds 2.17M shares in InspireMD (Ticker: NSPR), holds 12.50K shares in EyePoint Pharmaceuticals (Ticker: EYPT).
James J. Barry has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James J. Barry holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by James J. Barry
James J. Barry's Trading History
InspireMD
Dec 17, 2019
President & CEO, Director
Uninformative Buy
―
$4.57M
BioSig Technologies
Aug 18, 2023
Director
Uninformative Buy
―
$90.49K
EyePoint Pharmaceuticals
May 14, 2018
Director
Uninformative Buy
―
$144.50K
List of latest transactions for each holding click on a transaction to see James J. Barry's performance on stock
You May Also Like
James J. Barry insider profile FAQ
What is the percentage of profitable transactions made by James J. Barry?
The percentage of profitable transactions made by James J. Barry is ―.
What is the average return per transaction made by James J. Barry?
The average return per transaction made by James J. Barry is ―.
What stocks does James J. Barry hold?
James J. Barry holds: NSPR, BSGM, EYPT stocks.
What was James J. Barry’s latest transaction?
James J. Barry latest transaction was an Uninformative Buy of ―.
What was James J. Barry's most profitable transaction?
James J. Barry’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is James J. Barry's role in InspireMD?
James J. Barry's role in InspireMD is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.